Evaluation of Educational Tools for Pregnant Women

December 2, 2014 updated by: Nadine Sauvé, Université de Sherbrooke

Evaluation of Educational Tools Concerning Hypertension in Ambulatory Pregnant Women, Compared With Usual Antenatal Care

Hypertensive disorders of pregnancy happen in 5% of pregnancies. Being aware of symptoms and complications may help women to present early and preserve their own and their baby's health.

The proposed research aims to evaluate the impact of educational tools in pregnant women from an ambulatory population. These tools include a detailed pamphlet (including a graphic-based summary), a magnet summarizing symptoms and appropriate action, and a video. Level of knowledge will be evaluated after one month with a validated questionnaire. We will also evaluate if getting more information about preeclampsia increases patient anxiety as well as satisfaction about the tools.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background: Preeclampsia is a leading cause of maternal/fetal morbidity/mortality. Pregnant women are often poorly informed on preeclampsia and seeking care too late results in maternal/fetal complications. Many healthcare providers believe that delivering information for low-risk women only make them more anxious.

Preliminary data: We published that an information pamphlet on preeclampsia increases knowledge, without increasing anxiety, and generates high satisfaction in women hospitalized for preeclampsia.

Objectives: Demonstrate that (1) ambulatory low-risk pregnant women will benefit from the pamphlet/video with improved knowledge; (2) without any increase in anxiety, and with great satisfaction.

Design: Prospective randomized controlled pilot study. Inclusion criteria: consecutive pregnant women aged ≥18 y.o. between 200-326 weeks presenting at the clinic and who read/write French or English. Exclusion criteria: Anticipated delivery or termination within one month. Intervention: pamphlet, magnet and video. Control: no educational tool. At baseline, women in both groups will answer questionnaire #1 on demographics; one month later: self-administered questionnaire #2 on knowledge, anxiety, satisfaction.

Sample size: N=178 will provide 80% power to find a significant improvement of at least 20% in knowledge score and 96% power to find a difference of at least 1 on scale for anxiety (alpha of 5%). Assuming a drop-out rate of 10%, missing answers <20%, and rate of answered questionnaire #2 of 50%, 400 subjects will be recruited.

Anticipated results: The tools will improve knowledge by about 20% in intervention group compared to control group. They will not increase anxiety over one point and will be highly appreciated by women.

Study Type

Interventional

Enrollment (Actual)

247

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Sherbrooke, Quebec, Canada, J1H 5N4
        • Centre Hopitalier Universiatire de Sherbrooke

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women between 20+0 to 32+6 weeks pregnant
  • Aged 18 years old or more
  • Who present at the Blood Sampling in Pregnancy clinic
  • With an adequate understanding of written and spoken French or English in order to read the pamphlet and fill out the self-administered questionnaire

Exclusion Criteria:

  • Consideration of an interruption of pregnancy for maternal or fetal reasons
  • Anticipated delivery within the next month.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: educational tools
Subjects will receive at time 0 the educational tools (pamphlet-including a graphic-based summary, a magnet and a 12 minutes video). They will then have to answer a questionnaire 1 month later about knowledge, anxiety and satisfaction.
Subjects will receive the educational tools. They will then receive one month after a questionnaire about knowledge, anxiety and satisfaction.
Other Names:
  • Pamphlet (including a graphic-based summary)
  • Magnet-summary
  • Video
No Intervention: Usual antenatal care
Subjects in this group will not receive any more educational tools that what is generally offered in routine antenatal care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge about preeclampsia
Time Frame: 1 month
Through a questionnaire (7 questions, 35 statements, one global score)
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: 1 month
Question 1: 8 statements (Likert's scale 1 to 6) Question 2 more general
1 month
Satisfaction
Time Frame: 1 month
3 questions
1 month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sub-group analysis: age
Time Frame: 1 month
Diferences in outcomes between control and intervention groups according to group age
1 month
Sub-group analysis: parity
Time Frame: 1 month
Differences between control and intervention group according to parity.
1 month
Sub-group analysis: pre-pregnancy BMI
Time Frame: 1 month
Differences between control and intervention group according to pre-pregnancy BMI
1 month
Sub-group analysis: category of health care provider
Time Frame: 1 month
Differences between control and intervention group according to category of healthcare provider
1 month
Sub-group analysis: preeclampsia risk factors
Time Frame: 1 month
Differences between control and intervention group according to preeclampsia risk factors (pre-pregnancy diseases or a history of preeclampsia
1 month
Sub-group analysis: tobacco use
Time Frame: 1 month
Differences between control and intervention group according to tobacco use
1 month
Sub-group analysis:
Time Frame: 1 month
Differences between control and intervention group according to employment type
1 month
Sub-group analysis: ethnicity
Time Frame: 1 month
Differences between control and intervention group according to ethnicity
1 month
Sub-group analysis: socio-economic level
Time Frame: 1 month
Differences between control and intervention group according to socio-economic level
1 month
Sub-group analysis: educational level
Time Frame: 1 month
Differences between control and intervention group according to educational level
1 month
Sub-group analysis: marital status
Time Frame: 1 month
Differences between control and intervention group according to marital status
1 month
Sub-group analysis:video viewed on site vs. at home
Time Frame: 1 month
Differences between control and intervention group according to video viewed on-site vs. at home
1 month
Sub-group analysis:delay since last consultation of the tools
Time Frame: 1 month
Differences between control and intervention group according to delay since last consultation of the tools.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nadine Sauve, MD, Centre de recherche clinique of the Centre Hopitalier Universitaire de Sherbrooke

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

May 14, 2013

First Submitted That Met QC Criteria

May 16, 2013

First Posted (Estimate)

May 21, 2013

Study Record Updates

Last Update Posted (Estimate)

December 4, 2014

Last Update Submitted That Met QC Criteria

December 2, 2014

Last Verified

December 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preeclampsia

Clinical Trials on Educational tools

Subscribe